Resmed RMD
NYSE RMD
$224.99 -3.51 (-1.54%)
At close: Sep 18, 2026 · 4:00 PM EDT

Resmed (RMD) Gross Profit Growth (1y) (2010 - 2026)

Analysis

Resmed (RMD) Gross Profit Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (1y) (Qtr)
1 Abbott Laboratories 177.43 Bn 172.48 Bn 7.27 Bn 15.59%
2 Intuitive Surgical 139.20 Bn 134.11 Bn 1.96 Bn 21.17%
3 Medtronic 118.01 Bn 109.81 Bn 6.34 Bn 13.68%
4 Stryker 105.44 Bn 101.96 Bn 4.50 Bn 17.10%
5 Boston Scientific 62.90 Bn 62.60 Bn 3.85 Bn 12.38%
6 Edwards Lifesciences 50.87 Bn 46.72 Bn 1.35 Bn 13.54%
7 Dexcom 33.72 Bn 31.77 Bn 830.00 Mn 20.50%
8 Resmed 32.45 Bn 30.98 Bn 861.22 Mn 5.02%
9 Alcon 31.70 Bn 30.25 Bn 1.68 Bn 20.68%
10 Steris 20.01 Bn 19.54 Bn 684.20 Mn 8.95%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.02%
Mar 31, 2026 16.25%
Dec 31, 2025 16.96%
Sep 30, 2025 14.44%
Jun 30, 2025 14.61%
Mar 31, 2025 10.63%
Dec 31, 2024 16.13%
Sep 30, 2024 19.52%
Jun 30, 2024 15.90%
Mar 31, 2024 12.15%
Dec 31, 2023 11.60%
Sep 30, 2023 10.96%
Jun 30, 2023 18.16%
Mar 31, 2023 25.76%
Dec 31, 2022 14.95%
Sep 30, 2022 6.82%
Jun 30, 2022 6.48%
Mar 31, 2022 9.82%
Dec 31, 2021 9.05%
Sep 30, 2021 15.42%